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Background/Aims: Although gastric hyperplastic pol-
yps are usually considered as benign lesions, a low 
risk of carcinomatous conversion is currently recogni-
zed. We aimed to identify the characteristics of hyper-
plastic polyps undergoing neoplastic transformation. 
Methods: A total of 269 gastric hyperplastic polyps 
from 216 patients removed by endoscopic polypec-
tomy (EP) or surgical resection were enrolled in this 
study, and their endoscopic pictures and pathology 
slides were reviewed. Results: Neoplastic transforma-
tion was detected on forceps biopsy specimen in 11 
cases. However, the pathology findings from the EP 
or surgical specimen revealed neoplastic transforma-
tion in 14 cases (5.2%; 4 with dysplasia and 10 with 
adenocarcinoma). No significant difference was found 
between hyperplastic polyps with and without neo-
plastic transformation in age, sex, location, number of 
polyps or gross appearance. However, neoplastic 
transformations were more frequently found in gastric 
hyperplastic polyps ＞1 cm than in polyps ≤1 cm (12 
of 143; 8.4% vs. 2 of 126; 1.6%) (p=0.013). Conclu-
sions: Neoplastic transformations were more frequ-
ently found in gastric hyperplastic polyps ＞1 cm. 
Therefore, EP should be considered for gastric hyper-
plastic polyps ＞1 cm for the accurate diagnosis and 
definitive treatment. (Gut and Liver 2009;3:271-275)
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INTRODUCTION
  Gastric hyperplastic polyps are lesions characterized by 
hyperplastic, elongated, or dilated foveolar epithelium 
within a congested and inflamed lamina propria.
1 They 
comprise approximately 70 to 90% of all gastric epithelial 
polyps.
1-3 Although gastric hyperplastic polyps are gen-
erally regarded as benign lesions, malignant transforma-
tions have been reported in several studies.
4-8 The re-
ported incidence of malignant transformation ranged from 
1.5 to 2.1% of gastric hyperplastic polyps.
4,6,9,10 Previous 
studies showed that the larger gastric hyperplastic polyps 
had a higher possibility of malignant transformation.
4,10,11 
Therefore, Rosen et al.
8 suggested that gastric hyperplastic 
polyps larger than 2 cm should be removed by either en-
doscopic or surgical resection. However, hyperplastic pol-
yps smaller than 2 cm in size have also been reported as 
showing malignant changes.
9,10,12 Furthermore, the diag-
nosis solely based on forceps biopsy specimens carries the 
risk of missing the neoplastic foci within hyperplastic pol-
yps due to sampling errors.
9,12,13 Actually, we recently ex-
perienced several cases whose initial diagnoses of gastric 
hyperplastic polyps based on forceps biopsy specimen 
were changed after endoscopic polypectomy (EP) was per-
formed; where the specimens obtained from same lesions 
revealed the coexisting dysplasia or cancer foci. For these 
reasons, some authorities have argued that gastric hyper-
plastic polyps exceeding 5 mm should be removed.
12,13 
However, considering the low risk of malignant trans-
formations and the complications and costs of EP or sur-272   Gut and Liver, Vol. 3, No. 4, December 2009
Table 1. Summary of Data on Gastric Hyperplastic Polyps with Neoplastic Transformations
No. Age (yr) Sex Site Size (cm)
Gross appearance
Biopsy finding Final diagnosis 
Shape Hyperemia Nodularity
 1 71 M HB/GC 3 P + + CA/HP CA/HP
 2 68 F HB/GC 3 P + - HP CA/HP
 3 56 F Cardia 3 P + - Dysplasia* CA/HP
 4 50 F MB/PW 2.8 P + + CA* CA/HP
 5 64 M LB/GC 1.8 P + + CA* CA/HP
 66 6 F L B / G C 1 . 5P+ + D y s p l a s i a *C A / H P
 7 64 M Ant/PW 1.5 P + + Dysplasia/HP CA/HP
 85 6 M C a r d i a 1 . 5P+ + C A / H P C A / H P
 9 60 M LB/AW 1.2 P + + CA/HP CA/HP
10 68 M LB/AW 0.8 S - - HP CA/HP
11 70 M HB/GC 3.5 P + + HP Dysplasia/HP
12 70 F MB/GC 3.5 P + + Dysplasia/HP Dysplasia/HP
13 59 M Ant/AW 2.6 P - + Dysplasia* Dysplasia/HP
14 49 F Ant/LC 0.5 P + + CA/HP Dysplasia/HP
M, male; HB, high body; GC, great curvature; P, pedunculated; CA, adenocarcinoma; HP, hyperplastic polyp; F, female; MB, mid 
body; PW, posterior wall; LB, low body; AW, anterior wall; S, sessile; Ant, antrum; LC, lesser curvature. 
*Initial forceps biopsies failed to identify the presence of hyperplastic polyp.
gical resection, it may be unreasonable and impractical to 
resect all gastric hyperplastic polyps exceeding 5 mm. 
Therefore, if we could identify the characteristics of hy-
perplastic polyps undergoing neoplastic transformation, it 
would be very helpful for making a clinical decision be-
tween endoscopic resection and close follow-up.
  In this study, we aimed to identify the characteristics of 
hyperplastic polyps undergoing neoplastic transformation. 
MATERIALS AND METHODS
1. Patients
  Between May 1995 and September 2008, a total of 355 
gastric hyperplastic polyps from 256 patients were re-
sected by EP or surgery at the Samsung Medical Center. 
After excluding the cases associated with polyposis syn-
drome (n=34) and cases without endoscopic pictures 
(n=52), a total of 269 gastric hyperplastic polyps from 
216 patients were finally enrolled in this study. Of these 
polyps, three were surgically removed and all the others 
were removed by EP. At our institution, EP is indicated 
and recommended for the lesion diagnosed as hyper-
plastic polyp by forceps biopsy if the lesion is ≥1.0 cm 
in size. In cases with a lesion ＜1.0 cm, we explain the 
natural history of hyperplastic polyp and the risks asso-
ciated with EP to the patients and discuss the treatment 
plan with them to decide between a resection and close 
follow-up. All the cases undergoing surgical resection 
were initially diagnosed to have cancerous transformation 
by forceps biopsy. All the patients undergoing EP or sur-
gery provided written informed consent for the proce-
dures.
  Endoscopy reports were reviewed for size and location 
of gastric hyperplastic polyp. In this study, the size was 
defined as the longest diameter of the lesion measured by 
biopsy forceps during endoscopy procedure. Endoscopy 
pictures were reviewed for shape of lesion, presence of 
hyperemia and presence of nodularity. This review was 
performed by an experienced endoscopist (A.R. Han) who 
was blinded to the original pathological results. Medical 
records were also reviewed for clinical features using hos-
pital intranet resources. The histopathology of the speci-
m e n s  w a s  r e v i e w e d  b y  a n  e x p e r i e n c e d  p a t h o l o g i s t  ( C . O .  
Sung) who had no information on the original patho-
logical results. The diagnosis of malignant transformation 
and gastric dysplasia was based on the Vienna classi-
fication of gastrointestinal neoplasia.
14
2. Statistical analysis
  Comparisons of clinicopathological and endoscopic data 
between the hyperplastic polyps with and without neo-
plastic transformation were performed using Pearson χ
2 
test, Fisher’s exact test and Mann-Whitney U test. Values 
of p＜0.05 were considered to be significant.
RESULTS
1. Gastric hyperplastic polyps with neoplastic tran-
sformation
    Among the 269 gastric hyperplastic polyps enrolled, Han AR, et al: Gastric Hyperplastic Polyps with Neoplastic Transformations   273
Fig. 1. Endoscopic finding of the case of hyperplastic polyp 
with neoplastic transformation. A 3.5 cm sized pedunculated 
lesion was observed at the greater curvature side of the high 
body. The polyp showed nodular surface and hyperemic 
discoloration. The pathology findings from the forceps biopsy 
showed hyperplastic polyp. However, pathology findings 
following endoscopic mucosal resection showed dysplasia 
arising from hyperplastic polyp. 
Fig. 2. Endoscopic finding of the case of hyperplastic polyp 
with malignant transformation. A 1.5 cm sized pedunculated 
lesion was observed at the posterior portion of the antrum. 
The polyp showed nodular surface and hyperemic discolo-
ration. The pathology findings from the forceps biopsy showed 
hyperplastic polyp with dysplasia. However, pathology findings 
following endoscopic mucosal resection showed adenocar-
cinoma arising from hyperplastic polyp.
Fig. 3. Micrograph of an adenocarcinoma arising from a 
hyperplastic polyp (circle) (H&E stain, ×40). Dysplastic foci 
were found around the cancerous components (square). 
Fig. 4. Micrograph of a hyperplastic polyp with dysplasia 
(H&E stain, ×100). The boundary between the dysplastic foci 
and the hyperplastic foveolar epithelium was distinct (long 
arrow).
fourteen polyps showed neoplastic transformations in 
EMR or surgical specimens. Characteristics of these four-
teen hyperplastic polyps with neoplastic transformation 
are shown in Table 1. There were 8 (57%) males and 6 
(43%) females. The median age was 64 years with a 
range of 49-71 years. Initial diagnoses by endoscopic for-
ceps biopsy were as follows; hyperplastic polyps in 3 cas-
es, gastric dysplasia in 5 cases and adenocarcinoma in 6 
cases. Gastric hyperplastic polyps were single in 10 (71%) 
patients and multiple in 4 (29%) patients. The body was 
the most common location of these polyps, which were 
distributed as follows: 9 (64%) in the body, 3 (22%) in 
the antrum and 2 (14%) in the cardia. One (7%) gastric 
polyp was sessile and ten (93%) were pedunculated. The 
size of these polyps ranged from 0.5 cm to 3.5 cm in 
their major diameter. Only two (14%) of these polyps 
were smaller than 1 cm, while twelve (86%) were larger 
than 1 cm. Twelve (86%) hyperplastic polyps showed 274   Gut and Liver, Vol. 3, No. 4, December 2009
Table 2. Comparison Data on Gastric Hyperplastic Polyps 
with or without Neoplastic Transformations
Neoplastic
(n=14)
Non-neoplastic
(n=255)
p-value
Sex 
  Male  8 (57%) 126 (49%) 0.573
  Female  6 (43%) 129 (51%)
Age median (range) 64 (49-71)  61 (27-81) 0.383
Site 
  Antrum  3 (22%) 147 (57%) 0.134
  Body   9 (64%)  99 (39 %)
  F u n d u s  0   2  ( 1 % )
  Cardia  2 (14%)   7 (3%)
Gross appearance
  Shape
    Sessile  1 (7%)  36 (14%) 0.700
    Pedunculated 13 (93%) 219 (86%)
  Hyperemia  
    Present    12 (86%) 225 (88%) 0.676
    Absent  2 (14%)  30 (12%)
  Nodularity
    Present 11 (79%) 127 (50%) 0.052
    Absent  3 (21%) 128 (50%)
Mean number of 1.8 1.7 0.782
 HPs per patients
Size of polyp
  Size ≤1 cm  2 (14%) 124 (49%) 0.013
  Size ＞1 cm 12 (86%) 131 (51%)
HP, hyperplastic polyp.
hyperemia. Eleven (79%) hyperplastic polyps showed 
nodularity (Figs. 1 and 2).
  As mentioned above, cancerous changes were found in 
10 (3.7%) of 269 hyperplastic polyps. Histology showed 
well or moderately differentiated tubular adenocarcinoma 
in nine lesions and papillary adenocarcinoma in one 
lesion. Nine of these cancers were localized to the mu-
cosal layer, and only one case showed invasion of the 
submucosal layer. Dysplastic changes were found around 
the cancerous components in all of the ten lesions. In 4 
(1.5%) of 269 gastric hyperplastic polyps, dysplastic 
changes were found. Three of these lesions showed 
high-grade dysplasia. The boundary between the dyspla-
stic area and hyperplastic component was comparatively 
distinct (Figs. 3 and 4).
2. Comparison of clinical and endoscopic features 
between the pure gastric hyperplastic polyps 
and gastric hyperplastic polyps with neoplastic 
transformation
  No significant difference was found between the age or 
sex of patients with hyperplastic polyps with or without 
neoplastic transformations. In addition, there was no sig-
nificant difference between the two groups in the num-
ber, location, or gross appearance of polyps (Table 2). 
However, neoplastic transformations were more frequen-
tly found in gastric hyperplastic polyps larger than 1 cm 
(12 of 143; 8.4%) than in polyps smaller than 1 cm (2 of 
126; 1.6%) (p=0.013).
DISCUSSION
  Gastric hyperplastic polyps are the most common gas-
tric polyps and are generally considered as relatively 
harmless lesions. However, several studies showed that 
malignant transformations occur in approximately 2% of 
gastric hyperplastic polyps.
4,6,9,10 I n  t h i s  s t u d y ,  f o u r t e e n  
(5.2%) of the 269 gastric hyperplastic polyps showed neo-
plastic transformations, and ten (3.7%) of these polyps 
contained cancerous components.
  The mechanism of carcinogenesis in gastric hyperplastic 
polyps is still unknown. However, it has been suggested 
that malignant transformations of gastric hyperplastic pol-
yps arise from the dysplastic epithelium rather than di-
rectly from the hyperplastic epithelium because cancerous 
lesions exist either in the dysplastic lesions or adjacent to 
the dysplastic lesions.
4,6,9,12 In this study, adenomatous 
changes were observed around the cancerous component 
in all of the gastric hyperplastic polyps with malignant 
transformations. Therefore, our study supports the pre-
vious findings that cancer cells arise from dysplastic areas 
in hyperplastic polyps rather than directly from the non-
dysplastic hyperplastic epithelium. In other studies, p53 
protein overexpression was detected in neoplastic compo-
nents of gastric hyperplastic polyps, and its incidence did 
not differ between polyps with dysplasia and those with 
carcinoma.
10,15 Yao et al.
15 suggested that p53 protein ac-
cumulation was associated with early phase carcino-
genesis in gastric hyperplastic polyps because of the high 
prevalence of immunoreactivity found in dysplasia.
  In this study, three of the hyperplastic polyps with neo-
plastic transformation failed to demonstrate any dysplastic 
foci on forceps biopsy. This discrepancy between the for-
ceps biopsy samples and endoscopically resected speci-
mens including whole hyperplastic polyps has been 
shown in other studies.
9,12,13 Therefore, a diagnosis based 
on the endoscopic forceps biopsy may sometimes be 
inaccurate. In our study, neoplastic transformations were 
more frequently found in gastric hyperplastic polyps larg-
er than 1 cm than in polyps smaller than 1 cm (8.4% vs 
1.6%). Other studies also showed that most hyperplastic 
polyps harboring cancer were larger than 1 cm in 
size.
4,9,16,17 Therefore, EP should be considered for gastric 
hyperplastic polyps larger than 1 cm to avoid the risk of Han AR, et al: Gastric Hyperplastic Polyps with Neoplastic Transformations   275
missing lesions with neoplastic transformations, although 
attention should also be paid to hyperplastic polyps less 
than 1 cm.
  The present study was limited by the possible selection 
bias as this study enrolled and analyzed only the cases 
undergoing endoscopic or surgical resection. However, 
this kind of study design was inevitable as this study 
aimed to identify the characteristics of gastric hyperplastic 
polyps undergoing neoplastic transformations which were 
difficult to diagnose only by forceps biopsy specimens.
  In conclusion, we found that neoplastic transformations 
were more frequently found in gastric hyperplastic polyps 
＞1 cm than in polyps ≤1 cm. In addition, the results of 
this study showed the diagnoses solely based on forceps 
biopsy specimens carried the risk of missing dysplasia or 
cancer foci within gastric hyperpalstic polyps. Considering 
these points, EP should be considered for gastric hyper-
plastic polyps ＞1 cm to avoid the risk of missing the le-
sions with neoplastic transformations.
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